VisionSpring sold reading glasses as wage-raising tools, then RCTs proved the gains

Presbyopia — the age-related loss of near vision — affects roughly 80% of adults over 40, yet fewer than 20% of those affected in low- and middle-income countries own correction. In the Assam cohort that became the PROSPER trial, not a single participant owned glasses at baseline. For a tea picker, that means every leaf within arm's reach is blurry: slower picking, more errors, lower pay, exactly in the decade when household earnings peak in responsibility.

Founded in 2001 by optometrist Jordan Kassalow, VisionSpring attacked the market failure rather than the medicine: eyeglasses are a 700-year-old technology manufactured for under a dollar, but the optical market never built a channel for consumers earning under $4 a day. The fix was distribution — radically affordable glasses sold through partner organizations already embedded in workers' lives, on a high-volume, low-margin model that treats the sale, not the donation, as what makes the channel durable.

The proof arrived in 2018. In the PROSPER randomized trial, 751 Assam tea workers over 40 received either near glasses or nothing; glasses cost $10.20 per person including delivery, uptake ran to 94%, and the Lancet Global Health reported a substantial productivity increase for trivial cost. VisionSpring summarizes the trial evidence as a 22–32% productivity lift — numbers that let an estate manager treat glasses like fertilizer: cheap inputs with a measurable yield.

The model then compounded. A 2026 randomized follow-up (PROSPER II) put glasses to work in Karnataka garment factories — 682 workers, 99% women — and found a significant productivity gain, cheaper than management training. In 2022 MacKenzie Scott gave $15 million toward a $70 million 'Livelihoods in Focus' plan to reach 6 million workers by 2030, and by late 2025 VisionSpring was piloting eye-screening kiosks inside Indian post offices under a WHO–Universal Postal Union program: 5,000 people screened in five Assam offices, 80% of them first-time wearers.

Sell reading glasses as tools that raise wages.

The unit economics are absurd in the buyer's favor: glasses cost under $1 to make and the Assam trial measured the wage-relevant return at a fifth or more of output.

Selling rather than donating keeps the last mile sustainable — a partner earns margin on every pair, so the channel scales without subsidy per unit.

Randomized evidence converted a wellness nicety into a procurement decision employers could justify in spreadsheet terms.

Piggybacking on existing channels — estates, BRAC, post offices — deletes the fixed cost that killed rural optical retail.

First-time-wearer rates of 65–85% prove the market was untouched demand, not competition.

When the product is cheap and the market is stuck, distribution is the bottleneck. Quantify the wage effect with a trial and the buyer changes: charity becomes an employer procurement line.

VisionSpring's approach moved from social enterprise to global health infrastructure. Its screening methodology was adopted by WHO, and the WHO–Universal Postal Union alliance is testing reading-glasses counters inside post offices, starting with Assam. The 2026 PROSPER II result extended the evidence from tea gardens to manufacturing. With the MacKenzie Scott gift, the organization is targeting 6 million workers by 2030 and over $1 billion in unlocked earning potential — for a product that costs less than a dollar to manufacture.